BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19818811)

  • 1. Alpha-fluoromethylhistidine, a histamine synthesis inhibitor, inhibits orexin-induced wakefulness in rats.
    Yasuko S; Atanda AM; Masato M; Kazuhiko Y; Kazuki H
    Behav Brain Res; 2010 Feb; 207(1):151-4. PubMed ID: 19818811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
    Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
    Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexins activate histaminergic neurons via the orexin 2 receptor.
    Yamanaka A; Tsujino N; Funahashi H; Honda K; Guan JL; Wang QP; Tominaga M; Goto K; Shioda S; Sakurai T
    Biochem Biophys Res Commun; 2002 Feb; 290(4):1237-45. PubMed ID: 11811995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arousal effect of orexin A depends on activation of the histaminergic system.
    Huang ZL; Qu WM; Li WD; Mochizuki T; Eguchi N; Watanabe T; Urade Y; Hayaishi O
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9965-70. PubMed ID: 11493714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats.
    Iwasa T; Matsuzaki T; Kiyokawa M; Shimizu F; Minakuchi M; Kuwahara A; Maegawa M; Yasui T; Irahara M
    J Neuroendocrinol; 2007 Sep; 19(9):732-8. PubMed ID: 17680889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats.
    Jia X; Yan J; Xia J; Xiong J; Wang T; Chen Y; Qi A; Yang N; Fan S; Ye J; Hu Z
    Neuropharmacology; 2012 Feb; 62(2):775-83. PubMed ID: 21924278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro.
    Ishibashi M; Takano S; Yanagida H; Takatsuna M; Nakajima K; Oomura Y; Wayner MJ; Sasaki K
    Peptides; 2005 Mar; 26(3):471-81. PubMed ID: 15652654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain orexins and wake regulation in rats exposed to maternal deprivation.
    Feng P; Vurbic D; Wu Z; Strohl KP
    Brain Res; 2007 Jun; 1154():163-72. PubMed ID: 17466285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
    Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
    Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats.
    Tao R; Ma Z; McKenna JT; Thakkar MM; Winston S; Strecker RE; McCarley RW
    Neuroscience; 2006 Sep; 141(3):1101-5. PubMed ID: 16820265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular injection of orexin-A, but not orexin-B, induces arousal of layer-type neonatal chicks.
    Katayama S; Hamasu K; Shigemi K; Cline MA; Furuse M
    Comp Biochem Physiol A Mol Integr Physiol; 2010 Oct; 157(2):132-5. PubMed ID: 20595012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats.
    Jochem J; Zwirska-Korczala K; Zabielski R; Kato I; Kuwahara A
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():115-24. PubMed ID: 17244943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(A) receptors mediate orexin-A induced stimulation of food intake.
    Kokare DM; Patole AM; Carta A; Chopde CT; Subhedar NK
    Neuropharmacology; 2006 Jan; 50(1):16-24. PubMed ID: 16168444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on arousal effect of Orexin-A in rat in coma due to ischemic brain injury].
    Jia XB; Li LS; Ye JN; Zhang X
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):361-4. PubMed ID: 18549720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat.
    Takahashi K; Wang QP; Guan JL; Kayama Y; Shioda S; Koyama Y
    Regul Pept; 2005 Mar; 126(1-2):43-7. PubMed ID: 15620412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity.
    Thorpe AJ; Kotz CM
    Brain Res; 2005 Jul; 1050(1-2):156-62. PubMed ID: 15979595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents.
    Kolaj M; Coderre E; Renaud LP
    Neuroscience; 2008 Sep; 155(4):1212-20. PubMed ID: 18674591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.